Results 231 to 240 of about 99,179 (264)
Some of the next articles are maybe not open access.
Impact of the matrix metalloproteinase MMP-3 on dementia
Neurobiology of Aging, 2007Cerebral accumulation of beta-amyloid peptide (Abeta) is a central event in the pathogenesis of Alzheimer's disease (AD). Several proteases were shown to hydrolyze Abeta in vitro or in cell-based assays, and are likely candidates for a role in Abeta clearance in brain.
Nicole, Helbecque +3 more
openaire +2 more sources
Fundamental & Clinical Pharmacology, 2017
AbstractMatrix metalloproteinase (MMP)‐2 and matrix metalloproteinase‐9 are involved in many illnesses affecting pregnant women, including intrahepatic cholestasis of pregnancy (ICP), a serious liver abnormality during pregnancy. Epigallocatechin‐3‐gallate (EGCG) has been widely reported to inhibit activities of MMP‐2 and MMP‐9. We aimed to investigate
Mei Zhang, Meimei Xu
openaire +2 more sources
AbstractMatrix metalloproteinase (MMP)‐2 and matrix metalloproteinase‐9 are involved in many illnesses affecting pregnant women, including intrahepatic cholestasis of pregnancy (ICP), a serious liver abnormality during pregnancy. Epigallocatechin‐3‐gallate (EGCG) has been widely reported to inhibit activities of MMP‐2 and MMP‐9. We aimed to investigate
Mei Zhang, Meimei Xu
openaire +2 more sources
Zhonghua nei ke za zhi, 2016
To study the changes of matrix metalloproteinase-3 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1(TIMP-1) expression during congestive heart failure.Using the reverse transcriptase-polymerase chain reaction(RT-PCR) assay, we detected MMP-3 and TIMP-1 expression in 31 patients with rheumatic heart disease (RHD) and 8 health subjects. Cardiac
Xianmei, Wang +3 more
openaire +1 more source
To study the changes of matrix metalloproteinase-3 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1(TIMP-1) expression during congestive heart failure.Using the reverse transcriptase-polymerase chain reaction(RT-PCR) assay, we detected MMP-3 and TIMP-1 expression in 31 patients with rheumatic heart disease (RHD) and 8 health subjects. Cardiac
Xianmei, Wang +3 more
openaire +1 more source
Role of matrix metalloproteinase-3 in neurodegeneration.
Journal of neurochemistry, 2013Matrix metalloproteinase-3 (MMP-3) is a member of the class of zinc-dependent proteases known to degrade the extracellular matrix. MMP-3 activity is regulated at three different levels: gene expression, proteolytic activation of the zymogen, and inhibition by the endogenous tissue inhibitors of metalloproteinase.
Eun-Mee, Kim, Onyou, Hwang
openaire +1 more source
The biofilm matrix: multitasking in a shared space
Nature Reviews Microbiology, 2022Hans-Curt Flemming +2 more
exaly
Membrane-type 3-matrix metalloproteinase (MMP16)
2013Hsueh-Liang Fu, Rafael Fridman
openaire +1 more source
Membrane-type matrix metalloproteinase 3
2004Motoharu Seiki, Hiroyuki Nakamura
openaire +1 more source
Matrix product states and projected entangled pair states: Concepts, symmetries, theorems
Reviews of Modern Physics, 2021Juan Ignacio Cirac Sasturáin +2 more
exaly